Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Expert Opinion on Pharmacotherapy|May 10, 2016
Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetesXueying Tan, Jingbo HuExpert Opinion on Pharmacotherapy|November 17, 2015
Combination therapy for type 2 diabetes: dapagliflozin plus metforminXueying Tan, Jingbo HuAnnales D'Endocrinologie|April 11, 2016
Empagliflozin/Linagliptin: Combination therapy in patients with type 2 diabetesXueying Tan, Jingbo HuSaudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|October 19, 2016
Investigation for the quality factors on the tablets containing medicated pelletsXueying Tan, Jingbo HuExpert Opinion on Investigational Drugs|July 26, 2017
Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetesXueying Tan, Xiaojing Cao, Minzhi Zhou, et al.Expert Opinion on Pharmacotherapy|November 8, 2016
Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetesJingbo Hu, Ping Zou, Shuo Zhang, et al.Drug Delivery|July 15, 2017
Atorvastatin-loaded micelles with bone-targeted ligand for the treatment of osteoporosisYonghui Xie, Xueying Tan, Jian Huang, et al.Expert Opinion on Pharmacotherapy|April 9, 2020
Evaluating dasiglucagon as a treatment option for hypoglycemia in diabetesShujuan Li, Ying Hu, Xueying Tan, et al.Biomaterials Science|April 21, 2021
Correction: A mitochondria-targeted dual-functional aggregation-induced emission luminogen for intracellular mitochondrial imaging and photodynamic therapyYujie Zhang, Wendi Huang, Xueying Tan, et al.Biomaterials Science|February 11, 2021
A mitochondria-targeted dual-functional aggregation-induced emission luminogen for intracellular mitochondrial imaging and photodynamic therapyYujie Zhang, Wendi Huang, Xueying Tan, et al.Pageof 10